Monday May 20, 2019

Research Reveals, Cancer Patients Are More Likely To Use Marijuana

"Medical marijuana legislation has previously been associated with reduction in hospitalisations related to opioid dependence or abuse, suggesting if patients are in fact substituting marijuana for opioid, this may introduce an opportunity for reducing opioid-related morbidity and mortality,"

0
//
marijuana
The researchers found significantly increased use of marijuana over time -- likely reflecting increased availability due to legislative changes -- but they found stable rates of opioid use. Pixabay

Many cancer patients use marijuana and its usage has increased, a new study suggests. The findings, published in the journal CANCER, indicate 40.3 per cent cancer patients used marijuana within the past year, compared with 38 per cent of respondents without cancer.

“Prospective clinical trials are needed to quantify the efficacy of marijuana in cancer-specific pain as well as the risk of opioid misuse in this patient population,” said co-author Kathryn Ries Tringale from the University of California, San Diego.

drugs
They found patients with cancer were more likely to use prescription opioids than adults without cancer — 13.9 per cent versus 6.4 per cent. Pixabay

For the study, 826 people with cancer were matched to 1,652 controls.

The researchers found significantly increased use of marijuana over time — likely reflecting increased availability due to legislative changes — but they found stable rates of opioid use.

Doctor

“Prospective clinical trials are needed to quantify the efficacy of marijuana in cancer-specific pain as well as the risk of opioid misuse in this patient population,” said co-author Kathryn Ries Tringale from the University of California, San Diego. VOA

They found patients with cancer were more likely to use prescription opioids than adults without cancer — 13.9 per cent versus 6.4 per cent.

Also Read: Risk to Obscure Creature, Highlights Pangolin Seizures in Asia

“Medical marijuana legislation has previously been associated with reduction in hospitalisations related to opioid dependence or abuse, suggesting if patients are in fact substituting marijuana for opioid, this may introduce an opportunity for reducing opioid-related morbidity and mortality,” said lead author Jona Hattangadi-Gluth from the varsity. (IANS)

Next Story

Jury Grants $2 Billion to Couple Claiming ‘Glysophate’ in Roundup Weed Killer Caused Cancer

Vietnam said it would stop importing Roundup and other weed killers with the ingredient

0
cancer
FILE - Containers of Roundup are displayed on a store shelf in San Francisco, Feb. 24, 2019. VOA

For the third time in less than a year, a jury has ruled the main ingredient in a popular weed killer caused cancer in its users. A San Francisco jury Monday awarded more than $2 billion to a couple in their 70s who say glyphosate in Roundup weed killer gave them non-Hodgkin lymphoma.

The couple say they used Roundup for 35 years. Attorneys for the couple say numerous scientific studies show glyphosate led to cancer in both animal and human populations.

The World Health Organization has classified glyphosate as “probably carcinogenic to humans” and last month, Vietnam said it would stop importing Roundup and other weed killers with the ingredient.

cancer
The World Health Organization has classified glyphosate as “probably carcinogenic to humans”. Pixabay

Bayer, Roundup’s manufacturer, argued that hundreds of other scientific tests show glyphosate is safe and that the U.S. Environmental Protection Agency determined that when used as directed, glyphosate is not dangerous.

ALSO READ: ‘Canine Brucellosis’- A Dog Disease which can Hit Humans in Iowa

Bayer says it is disappointed by Monday’s verdict and plans to appeal. Two other juries in March and last August awarded multimillion-dollar settlements to Roundup victims, and thousands of other cases are pending against the company.

The Wall Street Journal reports the price of shares in Bayer has dropped 30% since its first courtroom defeat in August. The newspaper also says shareholders are angered the German-based company bought Monsanto last year when it sells a product suspected of causing cancer. (VOA)